Director / PDMR Shareholding
23 December 2016
Genedrive plc (the "Company")
1. |
Details of PDMR |
|||||
(a) |
Name |
Matthew Fowler |
||||
(b) |
Position/status |
Chief Financial Officer |
||||
(c) |
Initial notification/amendment |
Initial notification |
||||
2. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
(a) |
Description of the financial instrument |
Options over ordinary shares of 1.5 pence each. |
||||
(b) |
Nature of the transaction |
Grant of options pursuant to and in accordance with the terms of the Company's Share Option Scheme dated 28 November 2007. |
||||
(c) |
Price(s) and volume(s) |
|
||||
(d) |
Aggregated informationAggregated volumePrice |
N/A |
||||
(e) |
Date of the transaction |
22 December 2016 |
||||
(f) |
Place of the transaction |
Outside trading venue - shares to be admitted to AIM market of London Stock Exchange plc on exercise of options. |
For further details please contact:
genedrive plc
David Budd: CEO +44 (0)161 989 0245
Peel Hunt LLP
James Steel +44 (0)207 418 8900
Oliver Jackson
Consilium Strategic Communications
Chris Gardner +44 (0)203 709 5700
Matthew Neal
Laura Thornton
genedrive@consilium-comms.com